Dr. Manesh R. Patel, M.D.
Internal Medicine (Internal Medicine Physician)
2301 Erwin Road, Duke University Medical Center -
Durham, NC 27710
- Medicare participating
At a glance
- Medical school
- Emory University School of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 197
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Emory University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
NC license 200100077
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Duke University Hospital Durham, NC
Medical groups
- Duke Health Integrated Practice, Inc (3,185 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 197
- Services billed
- 393
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 127 | 110 |
| Critical care, first 30-74 minutes | 79 | 30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 73 | 73 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 34 | 34 |
| New patient office or other outpatient visit, 60-74 minutes | 22 | 22 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 15 | 15 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 21 payments worth $201,460 in total to this clinician.
| Roche Molecular Systems, Inc. | $188,290 |
|---|---|
| Regeneron Pharmaceuticals, Inc. | $12,378 |
| ModernaTX, Inc. | $750 |
| Janssen Global Services, LLC | $42.54 |
| Consulting Fee | $199,852 |
|---|---|
| Travel and Lodging | $994 |
| Food and Beverage | $615 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Roche Molecular Systems, Inc. Feb 25, 2025 | Consulting Fee | $188,290 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $3,604 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $3,604 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $1,802 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $1,802 |
| ModernaTX, Inc. Mar 20, 2025 | Consulting Fee | $750 |
| Regeneron Pharmaceuticals, Inc. Jul 25, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $351 |
| Regeneron Pharmaceuticals, Inc. Jun 16, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $180 |
| Regeneron Pharmaceuticals, Inc. Jul 21, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $162 |
| Regeneron Pharmaceuticals, Inc. Jun 16, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $141 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. Jul 25, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $351 |
| Regeneron Pharmaceuticals, Inc. Jul 21, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $162 |
| Regeneron Pharmaceuticals, Inc. Jul 21, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $46.29 |
| Regeneron Pharmaceuticals, Inc. Jun 16, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $180 |
| Regeneron Pharmaceuticals, Inc. Jun 16, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $141 |
| Regeneron Pharmaceuticals, Inc. Jun 16, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $35.25 |
| Regeneron Pharmaceuticals, Inc. Jun 13, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $35.25 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $3,604 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $3,604 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $1,802 |
| Regeneron Pharmaceuticals, Inc. May 16, 2025 | Consulting Fee | $1,802 |
| ModernaTX, Inc. Mar 20, 2025 | Consulting Fee | $750 |
| Roche Molecular Systems, Inc. Feb 25, 2025 | Consulting Fee | $188,290 |
| Janssen Global Services, LLC Jan 14, 2025 | Travel and Lodging travel to WASHINGTON, DC | $42.54 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $583,667 in research payments for these studies, mostly to the institutions running them.
- Study name not reported
Regeneron Pharmaceuticals, Inc. - SPYRAL AFFIRM
Medtronic, Inc. - Individual Project Agreement with Duke University for Cardiac Services for BAY2433334, study 19767
Bayer HealthCare Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.